The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the generic medication Carmustine Obvius (carmustine) for the treatment of non-Hodgkin’s lymphoma, Hodgkin’s ... Read more